NYSE
99.39USD
+3.58 (+3.74%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
19.2B
P/E
—
EPS
—
Beta
0.46
52W range
79.12-108.29
Day range
97.86–101.80
Open
101.00
Prev close
95.81
Volume
938.1K
Avg volume
2.3M
Dividend
0.96
IPO
2001-07-25
https://www.zacks.com/stock/news/2968285/zimmer-biomet-zbh-q2-earnings-and-revenues-beat-estimates?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|yseop_template_4-2968285 · 8/5/2026+0.60
https://seekingalpha.com/article/4915246-zimmer-biomet-does-slow-and-steady-still-win-the-race · 6/16/2026+0.80
https://www.zacks.com/stock/news/2932565/here-s-how-financial-strength-remains-a-key-advantage-for-gmed?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2932565 · 6/4/2026-0.40
https://www.cnbc.com/2026/05/11/jim-cramer-todays-market-punishing-stocks-harder-than-1999.html · 5/11/2026-0.60
https://www.zacks.com/stock/news/2904468/zimmer-biomet-zbh-earnings-expected-to-grow-what-to-know-ahead-of-next-week-s-release · 4/21/2026+0.20
https://www.globenewswire.com/news-release/2026/03/06/3251052/0/en/Zimmer-Biomet-Holdings-Inc-Investigated-by-the-Portnoy-Law-Firm.html · 3/6/2026-1.00
https://www.globenewswire.com/news-release/2026/03/06/3251059/0/en/Zimmer-Biomet-Holdings-Inc-Investigated-by-the-Portnoy-Law-Firm.html · 3/6/2026-1.00
https://www.seeitmarket.com/the-great-ai-squeeze-high-costs-to-weight-on-earnings-reports/ · 2/12/2026-0.20
https://www.zacks.com/stock/news/2829733/unveiling-zimmer-zbh-q4-outlook-wall-street-estimates-for-key-metrics?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|nfm_preview-2829733 · 2/5/2026+0.30
https://www.prnewswire.com/news-releases/zimmer-biomet-to-present-at-the-44th-annual-jp-morgan-healthcare-conference-302647147.html · 12/22/2025+0.10
https://www.zacks.com/stock/news/2800454/why-is-zimmer-zbh-up-5-3-since-last-earnings-report?cid=CS-STOCKNEWSAPI-FT-realtime_blog-2800454 · 12/5/2025+0.40
https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-zimmer-biomet-holdings-inc---zbh-302619751.html · 11/20/2025-1.00
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
